This is a firm fixed price purchase order awarded by the Department of the Army Medical Command to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the provision of ILLUMINA REAGENTS FOR USACEHR. The $429,892.20 contract has a completion date of December 4, 2017. Illumina has previously provided sequencing systems, reagents, and related services to support genomic research and diagnostics for various federal agencies. This award does not have a set-aside designation. The order is likely in support of the U.S. Army Center for Environmental Health Research (USACEHR) and its work in areas such as biological threat characterization. Illumina has a separate $3.3 million Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery for nucleic acid sequencing needs.